Targeting the epigenome with bioactive food components for cancer prevention.

Journal of Nutrigenetics and Nutrigenomics
Thomas Prates OngSharon Ann Ross

Abstract

Epigenetic processes participate in cancer development and likely influence cancer prevention. Global DNA hypomethylation, gene promoter hypermethylation and aberrant histone post-translational modifications are hallmarks of neoplastic cells which have been associated with genomic instability and altered gene expression. Because epigenetic deregulation occurs early in carcinogenesis and is potentially reversible, intervention strategies targeting the epigenome have been proposed for cancer prevention. Bioactive food components (BFCs) with anticancer potential, including folate, polyphenols, selenium, retinoids, fatty acids, isothiocyanates and allyl compounds, influence DNA methylation and histone modification processes. Such activities have been shown to affect the expression of genes involved in cell proliferation, death and differentiation that are frequently altered in cancer. Although the epigenome represents a promising target for cancer prevention with BFCs, few studies have addressed the influence of dietary components on these mechanisms in vivo, particularly on the phenotype of humans, and thus the exact mechanisms whereby diet mediates an effect on cancer prevention remains unclear. Primary factors that should be elu...Continue Reading

References

Apr 21, 1990·Lancet·D Trichopoulos
Mar 1, 1995·The American Journal of Clinical Nutrition·A E Rogers
Jan 1, 1994·Drug Metabolism Reviews·L A Poirier
Mar 7, 2002·The Journal of Nutrition·Matthew J RowlingKevin L Schalinske
Aug 7, 2002·Alcohol·Rosa M PascaleFrancesco Feo
Aug 7, 2002·The Journal of Nutrition·J Kevin DayDennis B Lubahn
Dec 11, 2002·The Lancet Oncology·Mukesh Verma, Sudhir Srivastava
May 2, 2003·Annals of the New York Academy of Sciences·Sharon A Ross
Jul 4, 2003·The Journal of Nutrition·James R Davie
Jul 16, 2003·Molecular and Cellular Biology·Robert A Waterland, Randy L Jirtle
Sep 19, 2003·Nutrition Reviews·Gary L Johanning, Chandrika J Piyathilake
Oct 23, 2003·Nature Reviews. Cancer·Young-Joon Surh
Aug 17, 2004·World Journal of Gastroenterology : WJG·Ying-Xuan ChenDe-Kai Qiu
Aug 18, 2004·Cancer Research·Melinda C MyzakRoderick H Dashwood
Aug 31, 2004·The Journal of Nutrition·J A Milner
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Partha M Das, Rakesh Singal
Jul 23, 2005·Molecular Pharmacology·Won Jun LeeBao Ting Zhu
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ming Zhu FangChung S Yang
Oct 6, 2005·Cell Cycle·Mario F Fraga, Manel Esteller
Nov 4, 2005·Carcinogenesis·Roderick H DashwoodEmily Ho
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Melinda C MyzakRoderick H Dashwood
Feb 18, 2006·Nature Reviews. Drug Discovery·Christine B Yoo, Peter A Jones
Feb 24, 2006·Nature Reviews. Cancer·Stephen B Baylin, Joyce E Ohm
Apr 25, 2006·Biological Trace Element Research·Eric O UthusCindy D Davis
May 3, 2006·Human Molecular Genetics·Pauline A Callinan, Andrew P Feinberg
Sep 26, 2006·Trends in Endocrinology and Metabolism : TEM·Leena Hilakivi-Clarke, Sonia de Assis
Sep 28, 2006·Journal of Agricultural and Food Chemistry·Nathalie Druesne-PecolloCatherine Chaumontet

❮ Previous
Next ❯

Citations

May 17, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Mukesh Verma
Jun 21, 2013·Expert Review of Molecular Diagnostics·Juan SandovalJosé Luis García-Giménez
May 20, 2015·Nutrients·Sougat MisraMikael Björnstedt
Jul 25, 2015·Biochemical Pharmacology·Antonio J León-GonzálezValérie B Schini-Kerth
Mar 12, 2016·International Journal of Radiation Biology·Tatsuhiko ImaokaShinji Yoshinaga
Apr 9, 2016·Immunity & Ageing : I & a·Giuseppe CarrubaAdele Traina
Aug 5, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Juliana Xavier de MirandaThomas Prates Ong
Jul 15, 2015·Clinical Epigenetics·Christian BuschSascha Venturelli
Dec 24, 2014·The Journal of Nutritional Biochemistry·Andrea Di FrancescoClaudio D'Addario
Oct 16, 2013·Cancer Letters·Christelle JohnsonJason W Locasale
May 18, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia NovíoMaría Jesús Núñez-Iglesias
Jun 30, 2016·PloS One·Rubiceli Medina-AguilarCésar López-Camarillo
Sep 2, 2017·International Journal of Molecular Sciences·Christine Sturm, Anika E Wagner
Jan 29, 2016·Gene Regulation and Systems Biology·Cong-Jun LiWeizhong Li
Feb 13, 2018·International Journal of Cancer. Journal International Du Cancer·Kazuhiro DainoShizuko Kakinuma
Feb 14, 2016·BioMedicine·Ling-Chu Chang, Yung-Luen Yu
Jul 30, 2020·Medicina·Andrea Maugeri, Martina Barchitta
Jul 15, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eva Brglez MojzerUrban Bren
May 26, 2017·Cellular & Molecular Biology Letters·Damian StrzemeckiPaweł Grieb
Aug 19, 2017·Oxidative Medicine and Cellular Longevity·Gabriele PizzinoAlessandra Bitto
Nov 12, 2020·Materials·Rayssa de Sousa VictorRomualdo Rodrigues Menezes
Jul 21, 2021·Nutrition and Cancer·Mohsen TatarFakhraddin Naghibalhossaini
Oct 29, 2017·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Nadja NikolicJelena Milasin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.